Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Subscribe To Our Newsletter & Stay Updated
